Back to STATE STREET CORP STATE STREET CORP

TGTXTGTX
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in TG Therapeutics, Inc.

STATE STREET CORP holds 7.8M shares of TGTX (TG Therapeutics, Inc.), worth $427.8M as of 2026-Q2. The position was decreased (-10.0% shares). TGTX represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$427.8M

Current Shares

7.8M

Total Value Change

+$215.1M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7.8M
-10.0%
$427.8M0.0%$54.94
0
2026-Q1
Increased
8.6M
+2.0%
$287.3M0.0%$28.88
31
2025-Q4
Increased
8.5M
+4.7%
$252.8M0.0%$29.75
32
2025-Q3
Increased
8.1M
+6.3%
$292.6M0.0%$36.83
33
2025-Q2
Increased
7.6M
+2.5%
$274.2M0.0%$36.72
32
2025-Q1
Decreased
7.4M
-19.2%
$293.1M0.0%$39.86
0
2024-Q4
Increased
9.2M
+1.2%
$276.9M0.0%$31.44
31
2024-Q3
Increased
9.1M
+35.8%
$212.7M0.0%$23.83
40

Other major holders of TGTX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used